Aethlon Medical Inc - רווח נקי למניה בארבעת הרבעונים האחרונים AEMD

Aethlon Medical (AEMD) is managed by a team of experts focused on FDA compliance and reporting transparency. The rolling year net income per share trend visualizes fundamental stability, while 91.30 captures the current value of the indicator. The R&D center is developing the Hemopurifier system to combat oncology, while a strong engineering staff ensures technological progress in blood filtration.
Aethlon Medical Inc - פילוחים אנליטיים ומדדי מפתח (AEMD)

Net income per share dynamics determine the internal efficiency of the business. By analyzing the EPS YoY TTM relative growth rate, an investor assesses the percentage change in earnings over the last twelve months compared to the same period last year. This calculation filters out market noise, revealing a sustainable profitability trend. For Aethlon Medical (AEMD), such a metric reflects the monetization of R&D in the field of blood biofiltration. Growth in this indicator would confirm the commercial success of the company's innovative medical technologies.